Looking Back at the Lyon Oeil Rétine 2025 Congress

From 5 to 6 December 2025, Dr Lorane Béchet, an ophthalmologist at the Centre Médical des Aravis in Argonay, attended the Lyon Oeil Rétine congress. This major meeting brought together retinal specialists to discuss advances in diagnosis, treatment and surgery, with a shared goal: improving personalised care for patients.

---

🎯 Key Strengths and Medical Advances

🔹 Therapies for diabetic macular oedema and age-related macular degeneration (AMD)

Numerous sessions were dedicated to new therapeutic strategies to refine protocols and, where possible, reduce the frequency of injections. The discussions were based on real-life studies concerning:

• Eylea® 8 mg
• Vabysmo®
• Beovu®
• Illuvien®

🔹 Towards Precision Medicine

The focus was on the importance of ultra-precise diagnosis, particularly for characterizing the different types of neovascularization in AMD. This approach allows for tailoring treatment to the unique profile of each patient in order to optimize visual outcomes and quality of life.

🔹 Innovative Therapies Under Investigation

Several promising avenues, currently in the evaluation phase, were presented:

• Gene therapy: a future pathway for treating the underlying causes of diseases.
• The Port Delivery System: for prolonged and continuous delivery of treatments.
• Photobiomodulation: a new, non-invasive approach being studied for atrophic AMD.
• The AXORUS contact lens: an innovation aimed at achieving visual gains in atrophic AMD.

🔹 Retinal Surgery and Innovations

Experts debated the optimal timing for operating on epiretinal membranes and the increasing role of amnionic membranes in macular hole surgery, offering new perspectives for anatomical outcomes.

🔹 Dry Eye and Comfort

Particular attention was paid to managing dry eye in patients undergoing surgery or receiving repeated intravitreal injections. Preventive strategies were highlighted to ensure long-term visual comfort.

🔹 Cataract Surgery

Finally, material innovations (new implants) were discussed, enabling greater independence from glasses after surgery and catering to the active lifestyles of patients.